Enliven Therapeutics
ELVN
#3751
Rank
HK$26.84 B
Marketcap
HK$364.73
Share price
0.26%
Change (1 day)
115.48%
Change (1 year)

Earnings for Enliven Therapeutics (ELVN)

Earnings in 2026 (TTM): -HK$0.98 Billion

According to Enliven Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -HK$0.94 Billion a decrease over its 2024 earnings that were of -HK$0.82 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Enliven Therapeutics from 2022 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -HK$0.98 Billion3.63%
2025 -HK$0.94 Billion14.45%
2024 -HK$0.82 Billion25.17%
2023 -HK$0.66 Billion115.33%
2022 -HK$0.31 Billion